Literature DB >> 15509496

Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium.

B J Petro1, R C Tan, A L Tyner, M W Lingen, K Watanabe.   

Abstract

BRK is a non-receptor tyrosine kinase whose functional role is poorly understood. Although it is an epithelial specific kinase, its expression appears to be tissue specific. To date, little is known about BRK expression in human oral epithelium. We investigated expression of BRK in human oral squamous cell carcinomas (OSCC) and normal oral epithelium (NOE) using immunohistochemistry, laser confocal microscopy and Western blotting. The subcellular localization of BRK was identified by confocal microscopy and Western blotting of nuclear and cytoplasmic extracts from these cells. The results indicate that NOE express higher levels of BRK compared with OSCC cells. In NOE and moderately differentiated OSCC cells, BRK was localized in the nucleus and cytoplasm. However, in poorly differentiated OSCC cells, BRK was localized in perinuclear regions. These results suggest that BRK expression differs in normal and OSCC which may reflect a possible functional involvement in OSCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509496     DOI: 10.1016/j.oraloncology.2004.05.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  27 in total

1.  Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.

Authors:  Priya S Mathur; Jessica J Gierut; Grace Guzman; Hui Xie; Rosa M Xicola; Xavier Llor; Michael I Chastkofsky; Ansu O Perekatt; Angela L Tyner
Journal:  Mol Cancer Res       Date:  2016-03-16       Impact factor: 5.852

2.  Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine.

Authors:  Andrea Haegebarth; Wenjun Bie; Ruyan Yang; Susan E Crawford; Valeri Vasioukhin; Elaine Fuchs; Angela L Tyner
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

3.  Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance.

Authors:  Chuifeng Fan; Yang Zhao; Di Liu; Xiupeng Zhang; Enhua Wang
Journal:  Tumour Biol       Date:  2011-05-21

4.  Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6.

Authors:  Helena L Palka-Hamblin; Jessica J Gierut; Wenjun Bie; Patrick M Brauer; Yu Zheng; John M Asara; Angela L Tyner
Journal:  J Cell Sci       Date:  2009-12-21       Impact factor: 5.285

Review 5.  Brk/PTK6 signaling in normal and cancer cell models.

Authors:  Julie H Ostrander; Andrea R Daniel; Carol A Lange
Journal:  Curr Opin Pharmacol       Date:  2010-09-09       Impact factor: 5.547

6.  Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.

Authors:  You-Fang Chen; Gang Ma; Xun Cao; Zhi-Liang Huang; Mu-Sheng Zeng; Zhe-Sheng Wen
Journal:  Med Oncol       Date:  2014-11-07       Impact factor: 3.064

7.  Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.

Authors:  Monika Kasprzycka; Miroslaw Majewski; Zhi-Jong Wang; Andrzej Ptasznik; Maria Wysocka; Qian Zhang; Michal Marzec; Phyllis Gimotty; Mark R Crompton; Mariusz A Wasik
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 8.  Targeting protein tyrosine kinase 6 in cancer.

Authors:  Milica B Gilic; Angela L Tyner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-09-18       Impact factor: 10.680

9.  The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.

Authors:  Patrick M Brauer; Yu Zheng; Mark D Evans; Carmen Dominguez-Brauer; Donna M Peehl; Angela L Tyner
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

10.  Overexpression of PTK6 (breast tumor kinase) protein--a prognostic factor for long-term breast cancer survival--is not due to gene amplification.

Authors:  Michaela Aubele; Sanja Vidojkovic; Herbert Braselmann; Dominique Ritterswürden; Gert Auer; Mike J Atkinson; Soile Tapio; Heinz Höfler; Sandra Rauser; John M S Bartlett
Journal:  Virchows Arch       Date:  2009-07-21       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.